薬物検査の市場規模、シェア、動向分析レポート：製品別、サンプル別、薬物別、最終用途別、地域別、セグメント予測、2025年～2030年

薬物検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の薬物検査市場規模は2030年までに186億2,000万米ドルに達すると推定され、2025年から2030年にかけて5.1%のCAGRで成長すると予測されています。

革新的な検査のイントロダクション、薬物検査を義務付ける厳しい規制、薬物乱用と中毒の増加は、予測期間中の市場成長を促進すると予想される要因の一部です。

薬物乱用と中毒は世界の問題であり、何百万人もの人々に影響を及ぼしています。UNODCが発表したWorld Drug Reportによると、2019年には世界全体で約3,500万人が薬物使用障害に苦しんでいます。薬物乱用や薬物使用障害のこのような高い割合は、そのような症例を予防、治療、管理するための革新的な検査に対する大きな需要を生み出しています。この分野で事業を展開するいくつかの主要企業は、この需要の高まりに対応するため、革新的で効率的な製品を投入しています。

例えば、2019年6月、Quidel Corporationは、蛍光イムノアッセイ-Quidel Triage TOX Drug Screen, 94600を販売するための米国FDAの510（k）認可を受けた。これは尿中の代謝物や薬物の存在を検出するためのものです。さらに、2020年6月、コーダント・ヘルス・ソリューションズは、COVID-19パンデミックの間、裁判所と政府機関が参加者を監視するのを支援するために、ビデオ観察による口腔液薬物検査を提供しました。これは、パンデミック中に薬物乱用障害を持つ人々が直面するいくつかの課題との闘いに役立ちました。

政府の継続的な取り組みと、安全性を確保するための厳格な薬物乱用検査規制の実施により、検査製品に対する需要が高まっています。2020年7月、ニュージーランド政府は、国内での障害運転を減らすため、警察に運転者の無作為の路上薬物検査を実施する権限を与える新法案を提出しました。新法案では、コカイン、エクスタシー、大麻、アヘン、メタンフェタミン、ベンゾジアゼピンなどの物質が 促進要因に付着していないか、経口液検査でチェックすることができます。また、2020年2月、インド民間航空総局は、安全な空の旅を確保するため、パイロットと乗務員に対して、オピオイドや大麻などの精神作用物質に関する広範な検査を導入しました。

薬物検査市場レポートハイライト

• 消耗品セグメントは、2024年に34.6%の最大収益シェアを獲得。消耗品は検査に不可欠なもので、試薬、カラム、キット、キャリブレーター、検体、青色色素錠剤、温度試験ストリップ、コントロールなど、さまざまなアイテムが含まれます。
• 尿検体セグメントは2024年に77.7%の最大シェアを占めました。
• 2024年には、大麻／マリファナ・セグメントが市場を独占しました。このセグメントは市場全体の57.5％を占めました。これは、マリファナや大麻の違法薬物としての使用が世界中で増加しており、そのキットや器具の需要が生じていることに起因しています。
• 2024年には、薬物検査機関セグメントが市場を独占しました。これは、薬物検査機関の大きな存在感と提供物に起因しています。これらの検査機関の利点には、高速液体クロマトグラフィー（HPLC）や分光法などの高度な機器や、効果的な結果を得るための検査を実施するための訓練された人材が利用可能であることが含まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 薬物検査市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 薬物検査市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 薬物検査市場：製品の推定・動向分析

• 製品市場シェア、2023年および2030年
• セグメントダッシュボード
• 製品別世界の薬物検査市場の展望
• 2018年から2030年までの市場規模と予測および動向分析
  • 消耗品
  • 機器
  • 迅速検査装置
  • サービス

第5章 薬物検査市場： サンプルの推定・動向分析

• サンプル市場シェア、2023年と2030年
• セグメントダッシュボード
• サンプル別世界の薬物検査市場の見通し
• 2018年から2030年までの市場規模と予測および動向分析
  • 尿サンプル
  • 口腔液サンプル
  • 毛髪サンプル
  • その他のサンプル

第6章 薬物検査市場： 薬物の推定・動向分析

• 薬物市場シェア、2023年と2030年
• セグメントダッシュボード
• 薬物の見通しによる世界の薬物検査市場
• 2018年から2030年までの市場規模と予測および動向分析
  • アルコール
  • 大麻/マリファナ
  • コカイン
  • オピオイド
  • アンフェタミンとメタンフェタミン
  • LSD
  • その他

第7章 薬物検査市場：最終用途の推定・動向分析

• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 最終用途別世界の薬物検査市場の見通し
• 2018年から2030年までの市場規模と予測および動向分析
  • 薬物検査ラボ
  • ワークプレイス
  • 病院
  • その他

第8章 薬物検査市場：地域の推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 市場規模と予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2024 年
  • Quest Diagnostics Incorporated
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Laboratory Corporation of America Holdings
  • Clinical Reference Laboratory, Inc.
  • Cordant Health Solutions

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of abbreviation
• Table 3 North America drug testing market, by region, 2018 - 2030 (USD Million)
• Table 4 North America drug testing market, by product, 2018 - 2030 (USD Million)
• Table 5 North America drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 6 North America drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 7 North America drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 8 U.S. drug testing market, by product, 2018 - 2030 (USD Million)
• Table 9 U.S. drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 10 U.S. drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 11 U.S. drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 12 Canada drug testing market, by product, 2018 - 2030 (USD Million)
• Table 13 Canada drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 14 Canada drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 15 Canada drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico drug testing market, by product, 2018 - 2030 (USD Million)
• Table 17 Mexico drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 18 Mexico drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 19 Mexico drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 20 Europe drug testing market, by region, 2018 - 2030 (USD Million)
• Table 21 Europe drug testing market, by product, 2018 - 2030 (USD Million)
• Table 22 Europe drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 23 Europe drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 24 Europe drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 25 Germany drug testing market, by product, 2018 - 2030 (USD Million)
• Table 26 Germany drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 27 Germany drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 28 Germany drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 29 UK drug testing market, by product, 2018 - 2030 (USD Million)
• Table 30 UK drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 31 UK drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 32 UK drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 33 France drug testing market, by product, 2018 - 2030 (USD Million)
• Table 34 France drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 35 France drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 36 France drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 37 Italy drug testing market, by product, 2018 - 2030 (USD Million)
• Table 38 Italy drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 39 Italy drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 40 Italy drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 41 Spain drug testing market, by product, 2018 - 2030 (USD Million)
• Table 42 Spain drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 43 Spain drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 44 Spain drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 45 Denmark drug testing market, by product, 2018 - 2030 (USD Million)
• Table 46 Denmark drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 47 Denmark drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 48 Denmark drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 49 Sweden drug testing market, by product, 2018 - 2030 (USD Million)
• Table 50 Sweden drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 51 Sweden drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 52 Sweden drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 53 Norway drug testing market, by product, 2018 - 2030 (USD Million)
• Table 54 Norway drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 55 Norway drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 56 Norway drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific drug testing market, by region, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific drug testing market, by product, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 62 China drug testing market, by product, 2018 - 2030 (USD Million)
• Table 63 China drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 64 China drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 65 China drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 66 Japan drug testing market, by product, 2018 - 2030 (USD Million)
• Table 67 Japan drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 68 Japan drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 69 Japan drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 70 India drug testing market, by product, 2018 - 2030 (USD Million)
• Table 71 India drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 72 India drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 73 India drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 74 South Korea drug testing market, by product, 2018 - 2030 (USD Million)
• Table 75 South Korea drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 76 South Korea drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 77 South Korea drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 78 Australia drug testing market, by product, 2018 - 2030 (USD Million)
• Table 79 Australia drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 80 Australia drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 81 Australia drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 82 Thailand drug testing market, by product, 2018 - 2030 (USD Million)
• Table 83 Thailand drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 84 Thailand drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 85 Thailand drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 86 Latin America drug testing market, by product, 2018 - 2030 (USD Million)
• Table 87 Latin America drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 88 Latin America drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 89 Latin America drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 90 Brazil drug testing market, by product, 2018 - 2030 (USD Million)
• Table 91 Brazil drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 92 Brazil drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 93 Brazil drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 94 Argentina drug testing market, by product, 2018 - 2030 (USD Million)
• Table 95 Argentina drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 96 Argentina drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 97 Argentina drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 98 MEA drug testing market, by region, 2018 - 2030 (USD Million)
• Table 99 MEA drug testing market, by product, 2018 - 2030 (USD Million)
• Table 100 MEA drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 101 MEA drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 102 MEA drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 103 South Africa drug testing market, by product, 2018 - 2030 (USD Million)
• Table 104 South Africa drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 105 South Africa drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 106 South Africa drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia drug testing market, by product, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 111 UAE drug testing market, by product, 2018 - 2030 (USD Million)
• Table 112 UAE drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 113 UAE drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 114 UAE drug testing market, by end use, 2018 - 2030 (USD Million)
• Table 115 Kuwait drug testing market, by product, 2018 - 2030 (USD Million)
• Table 116 Kuwait drug testing market, by sample, 2018 - 2030 (USD Million)
• Table 117 Kuwait drug testing market, by drug, 2018 - 2030 (USD Million)
• Table 118 Kuwait drug testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information procurement
• Fig. 2 Primary research pattern
• Fig. 3 Market research approaches
• Fig. 4 Value chain-based sizing & forecasting
• Fig. 5 Market formulation & validation
• Fig. 6 Pathology Laboratories market segmentation
• Fig. 7 Market driver analysis (current & future impact)
• Fig. 8 Market restraint analysis (current & future impact)
• Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 10 Porter's five forces analysis
• Fig. 11 Drug testing market: Product movement analysis
• Fig. 12 Drug testing market: Product outlook and key takeaways
• Fig. 13 Consumables market estimates and forecast, 2018 - 2030
• Fig. 14 Instruments estimates and forecast, 2018 - 2030
• Fig. 15 Rapid Testing Devices market estimates and forecast, 2018 - 2030
• Fig. 16 Services estimates and forecast, 2018 - 2030
• Fig. 17 Drug testing market: Sample movement Analysis
• Fig. 18 Drug testing market: Sample outlook and key takeaways
• Fig. 19 Urine samples market estimates and forecasts, 2018 - 2030
• Fig. 20 Hair samples market estimates and forecasts, 2018 - 2030
• Fig. 21 Oral fluid samples market estimates and forecasts, 2018 - 2030
• Fig. 22 Others samples market estimates and forecasts, 2018 - 2030
• Fig. 23 Drug testing market: drug movement analysis
• Fig. 24 Drug testing market: drug outlook and key takeaways
• Fig. 25 Alcohol market estimates and forecasts, 2018 - 2030
• Fig. 26 Cannabis/Marijuana market estimates and forecasts, 2018 - 2030
• Fig. 27 Cocaine market estimates and forecasts, 2018 - 2030
• Fig. 28 Opioids market estimates and forecasts, 2018 - 2030
• Fig. 29 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030
• Fig. 30 Other market estimates and forecasts, 2018 - 2030
• Fig. 31 Drug testing market: end use movement analysis
• Fig. 32 Drug testing market: end use outlook and key takeaways
• Fig. 33 Drug testing laboratories market estimates and forecasts, 2018 - 2030
• Fig. 34 Workplaces market estimates and forecasts, 2018 - 2030
• Fig. 35 Hospitals market estimates and forecasts, 2018 - 2030
• Fig. 36 Others market estimates and forecasts, 2018 - 2030
• Fig. 37 Global drug testing market: Regional outlook and key takeaways
• Fig. 38 North America market estimates and forecasts, 2018 - 2030
• Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 40 Canada market estimates and forecasts, 2018 - 2030
• Fig. 41 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 42 Europe market estimates and forecasts, 2018 - 2030
• Fig. 43 UK market estimates and forecasts, 2018 - 2030
• Fig. 44 Germany market estimates and forecasts, 2018 - 2030
• Fig. 45 France market estimates and forecasts, 2018 - 2030
• Fig. 46 Italy market estimates and forecasts, 2018 - 2030
• Fig. 47 Spain market estimates and forecasts, 2018 - 2030
• Fig. 48 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 49 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 50 Norway market estimates and forecasts, 2018 - 2030
• Fig. 51 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 52 China market estimates and forecasts, 2018 - 2030
• Fig. 53 Japan market estimates and forecasts, 2018 - 2030
• Fig. 54 India market estimates and forecasts, 2018 - 2030
• Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 57 Australia market estimates and forecasts, 2018 - 2030
• Fig. 58 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 59 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 60 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 61 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 62 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 64 UAE market estimates and forecasts, 2018 - 2030
• Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 66 Market share of key market players- Drug testing market

Drug Testing Market Growth & Trends:

The global drug testing market size is estimated to reach USD 18.62 billion by 2030, registering to grow at a CAGR of 5.1% from 2025 to 2030 according to a new report by Grand View Research, Inc. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.

Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.

For instance, in June 2019, Quidel Corporation received the U.S. FDA's 510(k) clearance to market its fluorescence immunoassay-Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.

Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.

Drug Testing Market Report Highlights:

• The consumables segment captured the largest revenue share of 34.6% in 2024. Consumables are vital for testing and encompass a variety of items, including reagents, columns, kits, calibrators, specimens, blue dye tablets, temperature test strips, and controls.
• Urine samples segment accounted for the largest share of 77.7% in 2024, primarily due to their widespread acceptance and reliability.
• The cannabis/marijuana segment dominated the market in 2024. The segment accounted for 57.5% of the overall market. This can be attributed to the increasing use of marijuana or cannabis as an illicit drug in the world, creating a demand for its kits and instruments.
• The drug testing laboratories segment dominated the market in 2024. This can be attributed to drug testing laboratories' large presence and offerings. Advantages of these laboratories include the availability of sophisticated equipment, such as High-Performance Liquid Chromatography (HPLC) & spectroscopy, and trained personnel for conducting tests for effective results.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Sample
  • 1.2.3. Drug
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Sample outlook
  • 2.2.3. Drug outlook
  • 2.2.4. End Use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Drug Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High prevalence of substance abuse
    • 3.2.1.2. Stringent laws mandating alcohol and drug testing
    • 3.2.1.3. Increasing government initiatives to monitor substance abuse
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Drug testing is considered a violation of privacy rights in some countries
• 3.3. Drug Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Drug Testing Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Drug Testing Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Consumables
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Instruments
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Rapid Testing Devices
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Services
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Drug Testing Market: Sample Estimates & Trend Analysis

• 5.1. Sample Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Drug Testing Market by Sample Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Urine samples
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Oral fluid samples
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Hair samples
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Other Samples
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Drug Testing Market: Drug Estimates & Trend Analysis

• 6.1. Drug Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Drug Testing Market by Drug Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Alcohol
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. Cannabis/Marijuana
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Cocaine
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Opioids
    • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Amphetamine & Methamphetamine
    • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. LSD
    • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Others
    • 6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Drug Testing Market: End use Estimates & Trend Analysis

• 7.1. Ens Use Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Drug Testing Market by End Use Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. Drug Testing Laboratories
    • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 7.4.2. Workplaces
    • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Hospitals
    • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Others
    • 7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Drug Testing Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
  • 9.3.4. Quest Diagnostics Incorporated
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Abbott
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. F. Hoffmann-La Roche Ltd.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Quidel Corporation
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Thermo Fisher Scientific, Inc
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Siemens Healthcare GmbH
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Bio-Rad Laboratories, Inc.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Agilent Technologies, Inc.
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Laboratory Corporation of America Holdings
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Clinical Reference Laboratory, Inc.
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. Cordant Health Solutions
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives